“roche” Archives

in
Entry Author Date Location
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
Report: Biotech VCs Perpetuate Boardroom Gender Gap 01/24/17 National
A Year After CEO’s Departure, Quintessence Remains ‘Dormant’ 01/06/17 Wisconsin
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
Creating Bio “Gestalt” And Photos From New York Life Sciences 2021 12/19/16 New York
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Hurry and Save 20 Percent on NY Life Sciences 2021 12/08/16 New York
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Arrowhead Chief Scientific Officer David Lewis Among 34 Laid Off 12/01/16 Wisconsin
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
At NY Life Sci 2021, Yancopoulos, Dunn & More to Ponder NYC’s Bio Future 10/19/16 New York
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
In Battle Between Promega and Shareholders, Linton Heads to Court 08/02/16 Wisconsin
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Arrowhead Pharmaceuticals CEO on Name Change, Clinical Trial Progress 07/21/16 Wisconsin
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
3 Things You (Probably) Don’t Know about Indiana Innovation 07/05/16 Indiana
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups 06/08/16 New York
Page 2 of 19 « previous page · next page »